Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Science Translational Medicine|April 19, 2016
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge modelBeth D Kirkpatrick, Stephen S Whitehead, Kristen K Pierce, et al.The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.Plos Neglected Tropical Diseases|May 9, 2017
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationStephen S Whitehead, Anna P Durbin, Kristen K Pierce, et al.Journal of Virology|February 16, 2018
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph NodesSinthujan Jegaskanda, Rosemarie D Mason, Sarah F Andrews, et al.The Journal of Infectious Diseases|February 25, 2016
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody ResponseAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.The Journal of Infectious Diseases|March 25, 2015
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive AdultsBeth D Kirkpatrick, Anna P Durbin, Kristen K Pierce, et al.Biorxiv : the Preprint Server for Biology|May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.Pageof 3